Dylan Richards, PhD

Janssen Research & Development, LLC

Poster(s):

• D0389 - Differential and Combinatorial Mechanism of Action of Golimumab and Guselkumab in Ulcerative Colitis Induction Therapy: IL-23 Blockade Drives Restoration of Normal Epithelium and Mucosal Healing
  Tuesday, October 25, 2022

  10:00 AM – 12:00 PM ET